Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for managing Attention-Deficit/Hyperactivity Dysfunction in children and grown-ups . This functions as a prodrug, meaning https://apo-lisdexamfetamine-pri572536.tkzblog.com/42941749/vyvanse-in-this-country-a-comprehensive-guide